Your browser doesn't support javascript.
loading
Successful use of tofacitinib in reactive arthritis refractory to conventional therapies - a case series.
Maikap, Debashis; Padhan, Prasanta.
Afiliação
  • Maikap D; Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, Odisha 751024, India.
  • Padhan P; Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, Odisha 751024, India.
Mod Rheumatol Case Rep ; 6(2): 167-170, 2022 06 24.
Article em En | MEDLINE | ID: mdl-35024869
Reactive arthritis is an immune-mediated aseptic arthritis resulting from either genitourinary or gastrointestinal tract in a genetically susceptible host. It commonly presents as oligoarthritis of the lower limbs with or without extra-articular features such as urethritis and non-purulent conjunctivitis. Therapies include non steroidal anti inflammatory drugs (NSAIDs), conventional disease modifying anti-rheumatic drugs (DMARDs) and, rarely, biologics in severe cases. We report the successful use of tofacitinib in four cases of reactive arthritis who failed to respond to conventional therapies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reativa / Antirreumáticos Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: Mod Rheumatol Case Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reativa / Antirreumáticos Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: Mod Rheumatol Case Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido